House Democratic leaders are facing deep skepticism from their progressive wing over a plan empowering the government to limit prices for some expensive prescription drugs — a rift that could hurt the party on an issue that has also been embraced by President Donald Trump.
Liberal lawmakers and like-minded advocacy groups say the preliminary drug pricing plan pitched by House Speaker Nancy Pelosi is far too timid a response to spiraling U.S. drug costs, and could fail to leverage the government's massive purchasing power in demanding cheaper medicines.
